Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1981 |
100 Clinical Results associated with Tianjin Jinhong Shengli Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Tianjin Jinhong Shengli Pharmaceutical Co., Ltd.
100 Deals associated with Tianjin Jinhong Shengli Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Tianjin Jinhong Shengli Pharmaceutical Co., Ltd.